通过 ClinicalTrials.gov API v2 实时检索官方临床试验注册数据。触发词包括 ClinicalTrials.gov、临床试验、NCT、试验注册、招募状态、phase 1/2/3、RCT lookup、interventional trial、observational study。专注实时单次查询(≤1000 条/请求),适合"某试验最新状态/招募信息/主次要终点"场景。批量历史分析请用 aact-bulk-trials,文献检索用 pubmed-search/europepmc。
日本語の概要は準備中です。原文の説明を表示しています。
EthanYoQ/Skill-hub☆ 112026年10月5日 更新
Production-grade Bayesian causal inference with PyMC, CausalPy, and DoWhy. Enforces DAG-first thinking, mandatory user checkpoints for assumptions, design-specific refutation, and defensible reporting with causal language guardrails. Trigger on: causal inference, causal effect estimation, treatment effects, counterfactuals, difference-in-differences (DiD), synthetic control, regression discontinuity (RDD), interrupted time series (ITS), instrumental variables (IV), propensity scores, DAGs, causal graphs, confounders, backdoor criterion, do-calculus, interventional distributions, pm.do(), pm.observe(), CausalPy, DoWhy, mediation analysis, refutation, sensitivity analysis, parallel trends, placebo tests, or any question of the form "does X cause Y" or "what is the effect of X on Y."
日本語の概要は準備中です。原文の説明を表示しています。
brycewang-stanford/Auto-Empirical-Research-Skills☆ 4,6062026年10月12日 更新
Draft a clinical trial protocol synopsis with the elements regulators and IRBs expect. Use when asked to write a clinical trial protocol, a study protocol synopsis, a trial design, or to structure endpoints/eligibility/statistics for an interventional study. Produces a structured protocol synopsis — objectives, design, population with eligibility, interventions, endpoints, statistics, and safety/ethics — for expert review. (For non-clinical/UX research, use research-protocol.)
日本語の概要は準備中です。原文の説明を表示しています。
mohitagw15856/pm-claude-skills☆ 1,4412026年10月13日 更新
Bengio's causal inference for AI: Interventional reasoning, counterfactuals, and System 2 deep learning. World models with causal structure.
日本語の概要は準備中です。原文の説明を表示しています。
plurigrid/asi☆ 672026年7月10日 更新
Search the ClinicalTrials.gov registry through its version 2 REST API for interventional and observational studies, their phases, enrolment, endpoints, sponsors, and posted results. Use this skill to survey who is developing what against an indication, date a competitor's programme, read primary and secondary outcome measures, find eligibility criteria, and distinguish a study that completed from one that was terminated or withdrawn. Also trigger on ClinicalTrials.gov, NCT number, trial registry, study phase, enrolment, primary outcome measure, recruiting status, trial sponsor, or competitive landscape.
日本語の概要は準備中です。原文の説明を表示しています。
K-Dense-AI/drug-discovery-agent-skills☆ 372026年10月12日 更新
当用户询问 ClinicalTrials.gov / 临床试验 / NCT / 试验注册 / 招募状态 / phase 1/2/3 / RCT lookup / sponsor 检索 / interventional trial / observational study / 主次要终点 / trial outcomes / 试验招募中 / recruiting status 时,通过 ClinicalTrials.gov API v2 实时检索官方注册数据。专注实时单次查询(≤1000 条/请求),典型场景: "某 NCT 试验最新状态"、"BTK 抑制剂 Phase 3 在招募试验"、"某试验已发布的主次要终点结果"。明确边界: 批量 >10k 试验 / 全库 SQL 历史分析 → aact-bulk-trials; 关联 PubMed 文献 → pubmed-eutils; RCT 自动 GRADE 评级 → medical-evidence-grading; 引用入报告附录 → evidence-appendix-sync。跨平台无锁(Claude Code / Codex / Cursor 通用)。
日本語の概要は準備中です。原文の説明を表示しています。
EthanYoQ/Skill-hub☆ 112026年10月5日 更新
Explains ML predictions on omics data with SHAP, LIME, and permutation importance, handling the correlated-feature trap, the conditional-vs-interventional Shapley choice, and the attribution-is-not-causation boundary. Use when interpreting an omics classifier, debugging shortcut/batch learning, or deciding whether an attribution ranking can be trusted as biology. For validated feature selection see machine-learning/biomarker-discovery; explanations are not a selection method.
日本語の概要は準備中です。原文の説明を表示しています。
huang-sh/DeepScience☆ 42026年7月15日 更新